Using human cells, researchers developed a 3D experimental model that mimics the development of human bone marrow tissue that can be used to study chemotherapy toxicity.
Hosted on MSN19h
NICE green lights two blood cancer therapies for NHS useBMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback